Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 2
- Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
- CBD Market
Chair of UK’s FSA Says Future of CBD Regulation Will ‘Lie With EU Authorisations’
The long-term future of Britain’s CBD sector ‘really will lie with EU authorisations’, the chair of the Food Standards Agency (FSA) has told its board, a candid admission that the domestic regime the industry has chased for six years may ultimately be superseded by Brussels.
- Cultivation
Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
- Medical Cannabis
UK Medical Cannabis Under Review: Where is the ACMD Report?
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
- UK & Europe
Portugal’s Regulator Defends Cannabis Crackdown as Export Permit Delays Fall
Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
- CBD Market
FSA Backs Britain’s First CBD Food Authorisations as Brexit Deal Threatens to Override Them
Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications for ministerial approval in a move that could bring an estimated 3,000 products into legal compliance.
- CBD Market
French Trade Groups Prepare For Key CBD Ruling
Despite the Council of State knocking back its initial attempt to derail the French authorities’ latest crackdown on CBD, the head of the trade groups fighting the ban remain upbeat on its chances of success.
- International Regulation
Australia’s Medical Cannabis Reforms to Target ‘Closed Loop’ Prescribing
Australia’s ongoing efforts to restrict its medical cannabis market, now the largest outside North America, are now taking aim at the special access scheme (SAS) framework on which the country’s hundreds of thousands of annual prescriptions are based.
- Industry Trends
What’s in Store for the Global Cannabis Industry in 2026? Mid-Year Update
This article was updated on September 02, 2026 In December 2025, we asked our in-house team of experts how they expected to see the industry evolve over the coming year.
- US & Canada
DEA Makes Its Final Case for Cannabis Rescheduling as Full Hearing Transcripts Published
As Chief Administrative Law Judge Derek Julius weighs his recommendation on moving cannabis to Schedule III, the DEA’s own closing brief attacks nearly every witness who opposed it — bar one scientist inside its own ranks.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- International Regulation
Isreal Reopens Canadian Cannabis Dumping Case, This Time With a Route Around Its Finance Minister
Israel’s Ministry of Economy and Industry has already reopened its anti-dumping investigation into Canadian medical cannabis, just a week after a procedural defect forced the same case to close.
